CLEARCUT S SAFETY KNIFE

K110166 · Alcon Research, Ltd. · HNN · May 20, 2011 · Ophthalmic

Device Facts

Record IDK110166
Device NameCLEARCUT S SAFETY KNIFE
ApplicantAlcon Research, Ltd.
Product CodeHNN · Ophthalmic
Decision DateMay 20, 2011
DecisionSESE
Submission TypeAbbreviated
Regulation21 CFR 886.4350
Device ClassClass 1
AttributesTherapeutic

Intended Use

ClearCut™ S Incisional Instruments are sterile, single-use disposable devices intended for use during ophthalmic surgical procedures.

Device Story

ClearCut™ S Incisional Instruments are manual ophthalmic surgical instruments used by surgeons to create incisions during eye surgery. The device features an integral guard mechanism that can be activated to transition the blade between exposed and safe conditions, providing sharps injury prevention. The device is provided sterile, intended for single-use, and disposed of after the procedure. It is operated manually by a surgeon in a clinical/surgical setting. The device benefits the patient by facilitating precise surgical access while protecting healthcare personnel from accidental sharps injuries.

Clinical Evidence

No clinical data. Bench testing only. Testing included conformance to FDA guidance for sharps injury prevention features and biocompatibility evaluations per ANSI/AAMI/ISO 10993.

Technological Characteristics

Manual ophthalmic surgical instrument with integrated sharps protection guard. Single-use, disposable. Sterilized via gamma irradiation or ethylene oxide. Biocompatibility per ANSI/AAMI/ISO 10993.

Indications for Use

Indicated for use during ophthalmic surgical procedures as a sterile, single-use disposable incisional instrument.

Regulatory Classification

Identification

A manual ophthalmic surgical instrument is a nonpowered, handheld device intended to aid or perform ophthalmic surgical procedures. This generic type of device includes the manual corneal burr, ophthalmic caliper, ophthalmic cannula, eyelid clamp, ophthalmic muscle clamp, iris retractor clip, orbital compressor, ophthalmic curette, cystotome, orbital depressor, lachrymal dilator, erisophake, expressor, ophthalmic forcep, ophthalmic hook, sphere introducer, ophthalmic knife, ophthalmic suturing needle, lachrymal probe, trabeculotomy probe, cornea-sclera punch, ophthalmic retractor, ophthalmic ring (Flieringa), lachrymal sac rongeur, ophthalmic scissors, enucleating snare, ophthalmic spatula, ophthalmic specula, ophthalmic spoon, ophthalmic spud, trabeculotome or ophthalmic manual trephine.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ 510(k): k110166 #### 5. 510(K) SUMMARY MAY 2 0 2011 ### 510(k) Summary This summary document is being prepared in accordance with section 21 CFR 807.92(c). The submitter of the 510(k) is: Tonya Morgan Sr. Regulatory Analyst, Regulatory Affairs Alcon Research, Ltd. 6201 South Freeway Fort Worth, TX 76134 Phone: (817) 551-8723 Fax: (817) 302-4574 Date Summary Prepared: January 6, 2011 Device Subject to this 510(k): | Trade Name: | ClearCut™ S Incisional Instruments | |----------------------|---------------------------------------| | Common Name: | Ophthalmic Knife | | Classification Name: | Manual ophthalmic surgical instrument | #### 1. Predicate Devices: The legally marketed device(s) to which we are claiming substantial equivalence are: | 510(k) Number | Device | |---------------------------|--------------------------------| | Exempt per 21CFR 886.4350 | BD Beaver Safety Knife | | Exempt per 21CFR 886.4350 | KAI Safety Knife | | Exempt per 21CFR 886.4350 | Diamatrix ProTekt Safety Knife | #### 2. Device Description: The ClearCut™ S family of incisional instruments are manual ophthalmic surgical instruments used by surgeons to create surgical incisions during ophthalmic surgical procedures. Incisional instruments incorporating sharps protection features provide injury prevention to those who come in contact with the device. The instruments are designed with an integral guard that can be activated to place the blade in a safe or exposed condition. The product is {1}------------------------------------------------ delivered to the user terminally sterilized by either gamma irradiation or ethylene oxide sterilization methods. ### 3. Indications for Use: ClearCut™ S Incisional Instruments are sterile, single use disposable devices intended for using during ophthalmic surgical procedures. # 4. Brief Summary of Nonclinical Test and Results: The ClearCut™ S Incisional Instruments have been tested in conformance with the requirements set forth in the August 9, 2005, Guidance for Industry -- "Medical Devices with Sharps Injury Prevention Features." In addition, biocompatibility evaluations of materials coming in contact with the patient have been performed according to ANSI/AAMI/ISO 10993. Details of this testing can be found in Section 13. # 5. Comparison of Technological Characteristics to Predicate Devices: A comparison table of the ClearCut™ S Incisional Instruments and predicate devices is on the following page. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle-like symbol with three curved lines representing its body and wings. The symbol is positioned to the right of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA", which is arranged in a circular fashion around the left side of the symbol. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Alcon Laboratories, Inc. c/o Ms. Tonya Morgan Senior Regulatory Affairs Analyst 6201 South Freeway Fort Worth, Texas 76134 MAY 2 0 2011 Re: K110166 Trade/Device Name: ClearCut S Incisional Instruments Regulation Number: 21 CFR 886.4350 Regulation Name: Manual ophthalmic surgical instrument Regulatory Class: I Product Code: HNN Dated: April 12, 2011 Received: April 13, 2011 Dear Ms. Morgan: We have reviewed your Section 510(k) premarket notification of intent to market the device We have reviewed your Section 910(x) promance is substantially equivalent (for the indications referenced above and have determined the device is substantial in interstate referenced above and have determined the arrest breaked devices marketed in interstate for use stated in the encrosule) to regally manced people Amendments, or to commerce prior to May 28, 1976, the enactment date of the Federal Food. Drug commerce prof to May 20, 1970, the chartisens and the provisions of the Federal Food. Drug, devices that have been reciassince in accordance what approval application (PMA). and Cosmetic Act (Act) that do not require approval controls provisions of the Act. The and Cosmetic Act (Act) that do not require approvate of the general controls provisions of the Act. The You may, merelore, market me device, seejor to me a general controls provisions of the free mortion and prohibitions against misted to contract liability devices, good manufacturing practice, laboring, and joint the truthful and not misledge adulteration. Please note: CDNT docs not overaliate in the truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it and be If your device is classified (See above) mio times affecting your device can be may be subject to additional controls. Existing major regulations affective EDA may may be subject to additional Controls: "Existing major regard of 898. In addition, FDA may found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition found in the Code of I cacial resguines in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issualics of a substition with other requirements of the Act that FDA has made a determination that your device complies with of connection of th that FDA has made a determination that your are rederal agencies. You must or any Federal statules and regulations administered by only and to: registration and listing (21 {3}------------------------------------------------ CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Debrah Falls Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ### 4. INDICATIONS FOR USE STATEMENT Page _ of _1 £110166 510(k) Number (if known): ClearCut™ S Incisional Instruments (with Sharps Injury Device Name: Protection) Indications for Use: ClearCut™ S Incisional Instruments are sterile, single-use disposable devices intended for use during ophthalmic surgical procedures. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices 510(k) Number k110166 14
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...